UK's MHRA adds swine flu vaccines to ADR reports
This article was originally published in Scrip
Executive Summary
Following the launch of the UK's swine flu vaccination programme last week, the medicines regulator the MHRA has expanded its swine flu adverse drug reactions reporting tool to include GlaxoSmithKline's Pandemrix and Baxter's Celvapan H1N1 vaccines.